Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Cmed release Global Strategic and Regulatory Consulting Booklet

March 14, 2012 Research and Development

The regulatory environments within the industry continue to change and vary internationally. Cmed’s regulatory and medical professionals keep track of …
Feature
Press release
White paper

Europe’s pharma sector : living through the crisis

March 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma

Pharmaceutical markets across Europe have been badly hit by the economic crisis, with revenues in some countries being decimated by …
Feature
Pfizer picture

Pfizer pulls out of $350 million insulin pact

March 14, 2012 Research and Development, Sales and Marketing Biocon, Humalog, Lantus, NovoLog, Pfizer

Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …
News
Merck image

Merck warned over missing Januvia safety study

March 13, 2012 Research and Development FDA, Januvia, Merck, study

Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …
News

Catalent continues investment in Global Clinical Supply services with German warehousing & controlled substance expansion

March 13, 2012 Research and Development

Somerset, NJ – March 7, 2012 — Catalent Pharma Solutions announced the completion of extended warehousing facilities in Schorndorf, Germany …
News
Press release

Catalent Expert Presents on Protein Expression in CHO Cells: Comparison of GPEx® Technology to Traditional Cell Line Engineering at Cell Culture World Congress 2012

March 13, 2012 Research and Development

Somerset, NJ February 21, 2012 — Michael Jenkins, Ph.D., General Manager of Catalent Pharma Solutions’ Middleton, WI facility, will present …
News
Press release
john_brown

Dr John Brown joins BioCity Nottingham’s board

March 13, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BioCity Nottingham, BioCity Scotland, John Brown

Dr John Brown has been appointed as a non-executive director to the board of BioCity Nottingham Ltd, which runs one …
Appointment

GSK expands apprenticeship programme

March 13, 2012 Manufacturing and Production, Research and Development GSK, Hayes, R&D, manufacturing

GlaxoSmithKline has expanded its apprenticeship programme with the creation of positions spanning manufacturing, IT, and R&D.  The multi-disciplinary scheme is …
News
Zytiga image

Strong Zytiga study results could increase uptake

March 12, 2012 Research and Development, Sales and Marketing IDMC, Janssen, Provenge, Zytiga, prostate

Janssen’s prostate cancer pill Zytiga could be on course to target a larger number of patients following a positive late-stage …
News
roch_d_ucb

UCB chief executive to chair IMI

March 12, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing IMI, Roch, UCB

UCB has confirmed that its chief executive Roch Doliveux has been appointed chairman of the governing board of the Innovative …
Appointment
caprelsa image

Major new drugs for 2012

March 9, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Caprelsa, Eylea, Manjor new drugs, Xalkori, Zelboraf, avastin, inlyta

 Renal cell carcinoma Pfizer’s Inlyta (axitinib) has been approved as second line treatment for renal cell carcinoma. The drug is …
Feature

Keep Alzheimer’s patients on Aricept for longer, study says

March 8, 2012 Research and Development, Sales and Marketing Aricept, Pfizer, Teva, donepezil

Patients with severe forms of Alzheimer’s disease should stay on Pfizer’s Aricept for longer, according to new research. A new …
News
mark_baker_photograph2

NICE appoints two new directors

March 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Baker, NICE

The National Institute for Health and Clinical Excellence (NICE) has appointed two new directors. Professor Mark Baker will be the …
Appointment

Ranbaxy launches generic Lipitor in Europe

March 6, 2012 Research and Development, Sales and Marketing Lipitor, Pfizer, Ranbaxy, atorvastatin, generics

Ranbaxy has launched its generic version of Pfizer’s Lipitor in Europe, months ahead of its May expiration date.  The Indian …
News

Using the corporate brand in pharma

March 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Marks, MSI, brand, branding, brands

In many markets the corporate brand can add significant value and values to the portfolio of product brands and franchises. …
Feature
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026